KR960005148B1 - 활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템 - Google Patents

활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템 Download PDF

Info

Publication number
KR960005148B1
KR960005148B1 KR1019900003563A KR900003563A KR960005148B1 KR 960005148 B1 KR960005148 B1 KR 960005148B1 KR 1019900003563 A KR1019900003563 A KR 1019900003563A KR 900003563 A KR900003563 A KR 900003563A KR 960005148 B1 KR960005148 B1 KR 960005148B1
Authority
KR
South Korea
Prior art keywords
membrane
source
active substance
transdermal administration
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900003563A
Other languages
English (en)
Korean (ko)
Other versions
KR900013993A (ko
Inventor
뮬러 발터
Original Assignee
엘터에스 로만 테라피-시스테메 게엠베하 운트 콤파니 카게
프랑크 베허, 쥐르겐 마스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엘터에스 로만 테라피-시스테메 게엠베하 운트 콤파니 카게, 프랑크 베허, 쥐르겐 마스 filed Critical 엘터에스 로만 테라피-시스테메 게엠베하 운트 콤파니 카게
Publication of KR900013993A publication Critical patent/KR900013993A/ko
Application granted granted Critical
Publication of KR960005148B1 publication Critical patent/KR960005148B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
KR1019900003563A 1989-03-15 1990-03-14 활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템 Expired - Fee Related KR960005148B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3908431 1989-03-15
DE3908431A DE3908431A1 (de) 1989-03-15 1989-03-15 Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
DE3908431.0 1989-03-15

Publications (2)

Publication Number Publication Date
KR900013993A KR900013993A (ko) 1990-10-22
KR960005148B1 true KR960005148B1 (ko) 1996-04-22

Family

ID=6376396

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900003563A Expired - Fee Related KR960005148B1 (ko) 1989-03-15 1990-03-14 활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템

Country Status (26)

Country Link
EP (1) EP0387693B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0693921B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR960005148B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE143276T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU625402B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2012123C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ284770B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD292383A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3908431A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0387693T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2095216T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI901290A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3022033T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP930662A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU206991B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL93678A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY107420A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO300087B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ232895A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH26276A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL162693B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT93430B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI9010493B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK279357B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU48228B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA901941B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
DE4438989C2 (de) * 1994-09-16 1999-02-25 Lohmann Therapie Syst Lts Scopolaminpflaster
DE19705138A1 (de) * 1997-02-11 1998-08-13 Lohmann Therapie Syst Lts Dehnbares transdermales therapeutisches System
DE19733981A1 (de) * 1997-08-06 1999-02-11 Lohmann Therapie Syst Lts Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut
DE19738643C2 (de) 1997-09-04 2001-10-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
DE10056012A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Flexible Barrierefolie für ein Trägermaterial für medizinische Zwecke
DE10056014A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Mehrschichtige Trägerkonstruktion für wirkstofhaltige Pflastersyteme
DE102004020463A1 (de) * 2004-04-26 2005-11-10 Grünenthal GmbH Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel
EP2693929B1 (en) 2011-04-04 2018-09-12 The Procter and Gamble Company Home care article
MX355294B (es) 2011-08-15 2018-04-12 Procter & Gamble Artículos para el cuidado personal que tienen composiciones para el cuidado personal que tienen múltiples zonas amoldables.
US8795695B2 (en) 2011-08-15 2014-08-05 The Procter & Gamble Company Personal care methods
US9907738B2 (en) 2013-06-27 2018-03-06 The Procter & Gamble Company Personal care compositions and articles
DE102018216244A1 (de) 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Barriereschicht

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5755157A (en) * 1980-09-19 1982-04-01 Nitto Electric Ind Co Drug member having transcataneous absorbing property
IE53703B1 (en) * 1982-12-13 1989-01-18 Elan Corp Plc Drug delivery device
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device

Also Published As

Publication number Publication date
ZA901941B (en) 1990-12-28
PT93430A (pt) 1990-11-07
HU206991B (en) 1993-03-01
GR3022033T3 (en) 1997-03-31
IL93678A0 (en) 1990-12-23
SI9010493B (sl) 1999-02-28
CA2012123A1 (en) 1990-09-15
PH26276A (en) 1992-04-10
KR900013993A (ko) 1990-10-22
SK279357B6 (sk) 1998-10-07
JPH0316571A (ja) 1991-01-24
EP0387693A2 (de) 1990-09-19
ES2095216T3 (es) 1997-02-16
HUT53816A (en) 1990-12-28
DE59010514D1 (de) 1996-10-31
SI9010493A (sl) 1998-06-30
EP0387693A3 (de) 1990-12-19
FI901290A0 (fi) 1990-03-15
DK0387693T3 (da) 1997-03-17
NZ232895A (en) 1991-09-25
FI901290A7 (fi) 1990-09-16
HRP930662A2 (en) 1994-10-31
CS9001136A2 (en) 1991-11-12
YU49390A (sh) 1992-07-20
DE3908431C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-07-04
YU48228B (sh) 1997-08-22
PL162693B1 (en) 1993-12-31
MY107420A (en) 1995-12-30
JPH0693921B2 (ja) 1994-11-24
DE3908431A1 (de) 1990-09-27
NO300087B1 (no) 1997-04-07
EP0387693B1 (de) 1996-09-25
CZ284770B6 (cs) 1999-02-17
DD292383A5 (de) 1991-08-01
AU625402B2 (en) 1992-07-09
HU901422D0 (en) 1990-06-28
NO901128D0 (no) 1990-03-09
CA2012123C (en) 1997-05-20
AU5076590A (en) 1990-09-20
PT93430B (pt) 1996-06-28
IL93678A (en) 1995-01-24
ATE143276T1 (de) 1996-10-15
NO901128L (no) 1990-09-17

Similar Documents

Publication Publication Date Title
US4906463A (en) Transdermal drug-delivery composition
US5006342A (en) Resilient transdermal drug delivery device
US4769028A (en) Pharmaceutical product, in medical bandage form
US4758434A (en) Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
CA1337270C (en) Multilayer plaster
CA1297754C (en) Transdermal delivery device having a rate controlling adhesive
EP0483105B1 (en) Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers
US6791003B1 (en) Dual adhesive transdermal drug delivery system
US5314694A (en) Transdermal formulations, methods and devices
KR960005148B1 (ko) 활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템
EP0186071B1 (en) Transdermal system for timolol
US5176915A (en) Plaster used as therapeutic system for the administration of active substances to the skin which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
IE61788B1 (en) Transdermal therapeutic system
EP0144486A2 (en) Controlled-release drugsystem and process for preparing it
USRE34089E (en) Article useful for administration of pharmacologically-active substances transdermally, orally, or by means of implant
US5176917A (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
US5468501A (en) Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant
EP0523537B1 (en) Transdermal therapeutic system for the administration of drugs having bronchodilating activity
JPH01233212A (ja) 貼付剤
KR910003107B1 (ko) 에틸렌-비닐 아세테이트 기질 적층 구조의 방출 조절성 경피 흡수 제형

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

FPAY Annual fee payment

Payment date: 20070330

Year of fee payment: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20080423

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20080423